Position in ANIP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,310,836
+$11,310,836 QoQ
Shares Held
147,085
Ownership
0.647%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in ANIP
reported options exposure · as of Mar 31, 2026CallValue
$11,535,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ikarian Capital, LLC holds $37,161,250 across 6 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
543,047 | $19,147,837 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
This page
|
147,085 | $11,310,836 | |
| 3 | CRDL |
Cardiol Therapeutics Inc.
|
2,725,000 | $3,678,750 | |
| 4 | CPIX |
Cumberland Pharmaceuticals Inc
|
553,153 | $1,797,747 | |
| 5 | DERM |
Journey Medical Corp
|
251,436 | $1,179,234 | |
| 6 | SHPH |
Shuttle Pharmaceuticals Holdings, Inc.
|
68,993 | $46,846 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,310,836 | 147,085 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $11,535,000 | 150,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $6,536,232 | 82,800 | Call | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||